Clinical Trial Update: A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 translational study evaluating single-agent olaparib for advanced oesophagogastric cancer. The trial status is unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastro-oesophageal Junction Cancer
• Oesophageal Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Oesophageal Cancer, Gastro-Oesophageal Junction Cancer | Phase 2 | Status: UNKNOWN